Does PEXIDARTINIB Cause Product dose omission issue? 335 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 335 reports of Product dose omission issue have been filed in association with PEXIDARTINIB (Turalio). This represents 34.5% of all adverse event reports for PEXIDARTINIB.
335
Reports of Product dose omission issue with PEXIDARTINIB
34.5%
of all PEXIDARTINIB reports
3
Deaths
30
Hospitalizations
How Dangerous Is Product dose omission issue From PEXIDARTINIB?
Of the 335 reports, 3 (0.9%) resulted in death, 30 (9.0%) required hospitalization.
Is Product dose omission issue Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for PEXIDARTINIB. However, 335 reports have been filed with the FAERS database.
What Other Side Effects Does PEXIDARTINIB Cause?
Fatigue (378)
Hair colour changes (327)
Nausea (213)
Pruritus (186)
Aspartate aminotransferase increased (134)
Rash (131)
Off label use (130)
Alanine aminotransferase increased (124)
Diarrhoea (106)
Headache (103)
What Other Drugs Cause Product dose omission issue?
DUPILUMAB (18,189)
USTEKINUMAB (9,405)
GUSELKUMAB (9,267)
LENALIDOMIDE (8,145)
MEPOLIZUMAB (5,873)
TOFACITINIB (5,646)
VOXELOTOR (5,122)
BELIMUMAB (4,671)
SECUKINUMAB (4,572)
APREMILAST (4,460)
Which PEXIDARTINIB Alternatives Have Lower Product dose omission issue Risk?
PEXIDARTINIB vs PHENACETIN
PEXIDARTINIB vs PHENAZOPYRIDINE
PEXIDARTINIB vs PHENCYCLIDINE
PEXIDARTINIB vs PHENELZINE
PEXIDARTINIB vs PHENOBARBITAL